Sales and Marketing

Showing 15 posts of 11527 posts found.

Mixed bag for Genentech dementia drug

July 18, 2014 Research and Development, Sales and Marketing Alzheimer's, Genentech, crenezumab, dementia

A Phase II clinical trial for Genentech’s investigational Alzheimer’s drug failed to meet its primary endpoints – but the company …

Pfizer to pay $360m for InnoPharma

July 18, 2014 Sales and Marketing Pfizer, injectables, innopharma

Pfizer is to pay as much as $360 million for private pharma development company InnoPharma in a financial arrangement comprising …

New chairman for Leukemia & Lymphoma Society

July 18, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Leukemia & Lymphoma. jim davis

James Davis has been elected chairman of the national board of directors of The Leukemia & Lymphoma Society (LLS). Davis …

New drugs see J&J sales rise

July 17, 2014 Medical Communications, Sales and Marketing J&J, JJ, Q2, hepatitis C, olysio, sovaldi

Johnson & Johnson saw sales rise 9.1% to $19.5 billion year on year on the back of a strong performance …

Bayer hires litigation head from Pfizer

July 17, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Malini Moorthy, Pfizer

Bayer Healthcare has appointed Malini Moorthy to head up its litigation department in the US.  Moorthy joins the German firm from …

Lilly signs Immunocore deal

July 17, 2014 Research and Development, Sales and Marketing Cancer, Oxford, biotech, immunocore, lilly

Eli Lilly has signed a deal with one of the UK’s most high-profile biotech firms to research and potentially develop …

Deallus Consulting sees new chief executive

July 17, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Claudio D’Ambrosio, consulting, deallus

Life sciences consultancy firm Deallus Consulting has confirmed its new chief executive is to be Dr Claudio D’Ambrosio.  D’Ambrosio succeeds …

Migrants must pay more for treatment on NHS

July 16, 2014 Medical Communications, Sales and Marketing NHS, health tourism, migrants

Non-EU citizens will soon have to pay 150% of the cost of treatment on the NHS under new plans announced …

FDA speedy review for new Avastin licence

July 16, 2014 Research and Development, Sales and Marketing Cancer, Roche, avastin, cervical cancer

The FDA has granted priority review status for Roche’s Avastin (bevacizumab) plus chemotherapy in women with persistent, recurrent or metastatic …

Novartis makes Alzheimer’s deal

July 16, 2014 Research and Development, Sales and Marketing Alzheimer's, Genentech, Novartis, bai, epstein

Novartis is to collaborate with the Banner Alzheimer’s Institute (BAI) to test two of the Swiss company’s investigational anti-amyloid treatments. …

Merck Serono appoints R&D global head

July 16, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Luciano Rossetti, Merck Serono

Merck Serono the biopharma of division of US firm Merck has confirmed the appointment of Luciano Rossetti as its executive …

Novartis forms alliance with Google on ‘smart lens’

July 15, 2014 Medical Communications, Sales and Marketing Alcon, Novartis, diabetes, e-health, google, smart lens, wearable

Novartis eye care division Alcon has struck a deal with Google to develop a ‘smart’ contact lens designed to help …

Illumina ‘gets 100,000 Genomes contract’

July 15, 2014 Manufacturing and Production, Sales and Marketing Cambridge, DNA, DoH, NHS, genomes, illimina

Gene analysis specialist Illumina has been chosen to deliver a project to sequence 100,000 whole genomes from NHS patients by …

UK science minister steps down

July 15, 2014 Medical Communications, Sales and Marketing Cameron, UK, Willetts, cabinet, parliament, science minister

The science and universities minister David Willetts has resigned as British prime minister David Cameron carries out a major cabinet …

Targacept admits failure in Alzheimer’s trial

July 15, 2014 Research and Development, Sales and Marketing Alzheimer's, Aricept, Pfizer, TC-173, Targacept

Targacept is dropping a once promising Alzheimer’s drug from further clinical trials after it failed to beat Pfizer’s Aricept (donepezil) …
The Gateway to Local Adoption Series

Latest content